Key statistics
Short selling activityProvided by S&P Global Market Intelligence
Open | -- |
---|---|
High | -- |
Low | -- |
Bid | -- |
Offer | -- |
Previous close | -- |
Average volume | -- |
---|---|
Shares outstanding | 161.93m |
Free float | 147.47m |
P/E (TTM) | 55.75 |
Market cap | 34.80bn USD |
EPS (TTM) | 3.85 USD |
--
More ▼
Press releases
- Major Release of Veeva Site Connect Streamlines Clinical Trial Execution for Sites and Sponsors
- Veeva to Present at Upcoming Investor Conference
- Veeva Announces Fiscal 2025 Second Quarter Results
- New Service Center in Veeva Vault CRM Suite Unifies Sales and Service
- Veeva Vault LIMS Gains Momentum as Companies Unify Quality Assurance and Quality Control
- Life Sciences Community Advances Toward Next Phase of Innovation at Veeva R&D and Quality Summit
- Veeva to Release Fiscal 2025 Second Quarter Results on August 28, 2024
- Targeted Pre-Launch Scientific Outreach Drives 40% Faster Treatment Adoption
- Veeva Vault Quality Helps Neuraxpharm Drive Seamless Quality Operations and Collaboration With Over 100 CDMOs
More ▼